Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

3%

Threshold

Fell below threshold

Timeline

Published

12.09.2018

Transaction

04.09.2018

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBI9A00012

Beneficial owner

Frank-Jan van der Velden

Declared address

Frank-Jan van der Velden, Echteld

The conditional right to acquire new shares pursuant to a Combination Agreement entered with Kuros Biosciences AG (the Issuer ) on 18 December 2016 (the Combination Agreement ) whereas 1 365 000 shares of the Issuer were acquired at closing of the Combination Agreement and 740 000 shares of the Issuer were to be acquires on the achievement of certain product approval milestones has been exercised after full achievement of such milestones. The group of buyers has acquired all shares of the Issuer as provided in the Combination Agreement. The group shall therefore be terminated. A) Incubation B.V., Bilthoven, controlled by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Person 1 (Frank-Jan Van der Velden) and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Person 2 (Clemens van Blitterswijk); (B) Aldabra B.V., Amersfoort, the Netherlands, a company controlled by Person 3 (Joost de Bruijn) and (C) Person 4 (Yuan Huipin) shall acquire the shares.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open